Skip to main content
Log in

Assessing the current epidemiological status of SARS-CoV-2 and its potential evolution

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Coronavirus disease (COVID-19) Weekly Epidemiological Updates and Monthly Operational Updates. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports october-2023. Accessed October 22, 2023

  2. Harris E. CDC assesses risk from B.A2.86, highly mutated COVID-19 variant. JAMA. 2023;330:1029. https://doi.org/10.1001/jama.2023.16105.

    Article  PubMed  Google Scholar 

  3. WHO. Updated working definitions and primary actions for SARS-CoV-2 variants. 4 October 2023. https://www.who.int/publications/m/item/updated-working-definitions-and-primary-actions-for--sars-cov-2-variants. Accessed 19 October 2023.

  4. CDC. SARS-CoV-2 Variant Classifications and Definitions. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html#:~:text=In%20some%20cases%2C%20a%20lineage,Monitored%20(VBM)%20due%20to%20shared. Accessed 20 october 2023

  5. European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 7 September 2023. https://www.ecdc.europa.eu/en/covid-19/variants-concern. Accessed 22 September 2023.

Download references

Funding

The authors have no financial or non-financial interests to disclose. All authors exclude funding received for this work.

Author information

Authors and Affiliations

Authors

Contributions

All authors whose names appear on the submission - made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; - drafted the work or revised it critically for important intellectual content; - approved the version to be published; and - agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Nicola Abrescia.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interest

The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abrescia, N., D’Abbraccio, M., De Marco, M. et al. Assessing the current epidemiological status of SARS-CoV-2 and its potential evolution. Infection 52, 699–700 (2024). https://doi.org/10.1007/s15010-024-02190-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-024-02190-4

Navigation